Formulation for inhalation

Details Formulation for inhalation Formulation for inhalation

2005-08-09

2005-08-09

Dodson, Shelley A. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S045000, C424S046000, C514S003100, C514S005200

Reexamination Certificate

active

06926908

ABSTRACT:
Microparticles, obtainable by spray-drying a substantially pure solution of a therapeutic agent, consist essentially of the agent having its therapeutic activity when administered to the lung. In a preferred embodiment the agent is insulin.

REFERENCES:
patent: 3515642 (1970-06-01), Mima et al.
patent: 5354562 (1994-10-01), Platz et al.
patent: 5855913 (1999-01-01), Hanes et al.
patent: 6051256 (2000-04-01), Platz et al.
patent: 6451349 (2002-09-01), Robinson et al.
patent: 2136704 (1994-11-01), None
patent: 1 227 855 (1966-11-01), None
patent: 072 046 (1983-02-01), None
patent: 542 314 (1993-05-01), None
patent: 92/18164 (1992-10-01), None
patent: 94/08627 (1994-04-01), None
patent: 95/00127 (1995-01-01), None
patent: 95/23613 (1995-04-01), None
patent: 95/24183 (1995-09-01), None
patent: 96/32149 (1996-10-01), None
patent: 97/35562 (1997-10-01), None
Forbes et al. (1998) “Water vapour sorption sudies on the physical stability of a series of spray-dried protein/sugar powders for inhalation”J Pharm Sci87:1316-1321.
Veber et al. (1980) Preparations releasing cells from animal tissues or surfaces of cultivation vessels Chemical Abstracts 93 Abstract No. 13123.
Yeo et al. (1993) “Formation of microparticulate protein powders using a supercritical fluid antisolvent”Biotech and Bioeng41:341-346.
Chan et al. (1997) “Spray-dried powders and powder blends of recombinant human deoxyriboncuease (rhDNase) for aerosol delivery”Pharm Res14:431-437.
Chan et al. (1998) “Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (rhDNase)”J Pharm Sci87:647-654.
Niven et al. (1994) “Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor (rhG-CSF) to the rabbit”Pharm Res11:1101-1109.
Pikal et al. (1997) “The stability of insulin in crystalline and amorphous solids: Observation of greater stability for the amorphous form”Pharm Res14:1379-1387.
Timko et al. (1984) “Thermal analysis studies of glass dispersion systems”Drug Dev Ind Pharm10:425-451.
International Search Report on International Application No. PCT/GB99/02023.

Affiliated with

Also associated with

Rating

Formulation for inhalation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for inhalation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for inhalation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3491410